Lefamulin Post-Market Surveillance Study

Clinical trial NCT07697885 · RECRUITING

Trial details

NCT number: NCT07697885
Sponsor: Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Community-Acquired Pneumonia (CAP)

Start date: 2026-06-30
Primary completion: 2027-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.